Oncologic Safety and Lymphadenectomy in Parenchyma-Sparing Resection for SPN

Solid pseudopapillary neoplasm (SPN) of the pancreas is a low-grade malignant tumor primarily treated with surgical resection. However, the oncologic safety of parenchyma-sparing resection (PSR) and the necessity of lymphadenectomy remain debated. This prospective cohort study evaluates these aspects based on long-term outcomes.

NCT Number	NCT07592663
Lead Sponsor	Fudan University
Conditions	Pancreatic Tumor, Benign, Solid Pseudopapillary Tumor of the Pancreas
Enrollment	708 participants
Start Date	2008-07-01
Primary Completion	2026-03-01 (estimated)
Study Completion	2026-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-18